Form 4: Sabra Health Care REIT Director Receives Equity Grant, Aligning Interests

Ann Kono, a Director at Sabra Health Care REIT, Inc., was granted 8,178 restricted stock units as part of her compensation, aligning her interests with shareholders.

Summary

• Ann Kono, a Director of Sabra Health Care REIT, Inc. (SBRA), acquired 8,178 shares of common stock on June 12, 2025, through a grant of restricted stock units (RSUs).
• The RSUs were granted under the Issuer's 2009 Performance Incentive Plan.
• These 8,178 RSUs will vest in equal monthly installments, commencing on July 12, 2025, and concluding on the earlier of June 12, 2026, or the day prior to the next annual stockholders' meeting.
• Following this transaction, Ann Kono beneficially owns a total of 56,509 shares, which includes the newly granted 8,178 unvested RSUs and 48,331 stock units that have vested but whose payment has been deferred.
• Each stock unit represents the right to receive one share of Sabra Health Care REIT, Inc.'s Common Stock.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as the equity grant aligns the director's interests with shareholders, which is generally viewed favorably. It is a routine compensation event, not indicative of significant positive or negative news beyond that.

Positives

• The grant of restricted stock units to a director aligns management's interests with those of the shareholders, as the value of the compensation is tied to the company's stock performance.
• This is a standard form of equity compensation, indicating continued commitment to the company's long-term incentive plans.

Future Outlook

The restricted stock units granted to Director Ann Kono are scheduled to vest in equal monthly installments starting July 12, 2025, and concluding by June 12, 2026, or earlier, linking her future compensation to the company's performance over this period.

Industry Context

The grant of restricted stock units to a director is a common practice in the REIT (Real Estate Investment Trust) sector and broader corporate landscape, serving as a key component of executive and director compensation packages designed to incentivize long-term performance and align interests with shareholders.

Corporate Governance

Related Party Transactions

• The grant of 8,178 restricted stock units to Ann Kono, a Director of Sabra Health Care REIT, Inc., constitutes a related party transaction as it involves compensation provided by the issuer to a member of its board of directors.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's financial interests with the long-term performance of the company's stock, potentially benefiting shareholders through improved governance and strategic decisions.
• Employees: While not directly impacting employees, the use of equity incentives for leadership can signal a commitment to performance-based compensation across the organization.

Next Steps

• The restricted stock units will begin vesting in equal monthly installments starting July 12, 2025.
• The vesting period will continue until June 12, 2026, or the day before the next annual stockholders' meeting, whichever comes first.

Key Dates

Keywords

Sabra Health Care REIT, SBRA, SEC Form 4, Insider Transaction, Restricted Stock Units, Equity Compensation, Director Compensation, Stock Grant, Performance Incentive Plan